Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1471 | 0.3307 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Toxoplasma gondii | FAD binding domain-containing protein | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0507 | 0.114 |
Echinococcus granulosus | lamin | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.4448 | 0.4448 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1471 | 0.1471 |
Trypanosoma brucei | Monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0915 | 0.2058 |
Echinococcus multilocularis | protein MICAL 3 | 0.0138 | 0.4448 | 0.4448 |
Echinococcus granulosus | ubiquinone biosynthesis monooxygenase COQ6 | 0.0138 | 0.4448 | 0.4448 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0507 | 0.0507 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Chlamydia trachomatis | monooxygenase | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0507 | 0.0507 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0915 | 0.0915 |
Toxoplasma gondii | FAD binding domain-containing protein | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0915 | 0.0915 |
Trypanosoma cruzi | Monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0138 | 0.4448 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Mycobacterium ulcerans | FAD-linked oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | monoxygenase | 0.0138 | 0.4448 | 1 |
Trypanosoma brucei | kynurenine 3-monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0915 | 0.2058 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1544 | 0.1544 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0485 | 0.0485 |
Echinococcus multilocularis | ubiquinone biosynthesis monooxygenase COQ6 | 0.0138 | 0.4448 | 0.4448 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1544 | 0.1544 |
Plasmodium vivax | FAD-dependent monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1544 | 0.1544 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Schistosoma mansoni | lamin | 0.0033 | 0.0507 | 0.114 |
Plasmodium falciparum | FAD-dependent monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0829 | 0.1865 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1471 | 0.3307 |
Mycobacterium ulcerans | oxidoreductase GMC-type | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | membrane-associated oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 2-polyprenyl-6-methoxyphenol 4-hydroxylase | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0507 | 0.0507 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0915 | 0.0915 |
Schistosoma mansoni | lamin | 0.0033 | 0.0507 | 0.114 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0829 | 0.0829 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1544 | 0.1544 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0507 | 0.0507 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0507 | 0.0507 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | FAD-dependent oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Mycobacterium leprae | possibleputative FAD-linked oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | protein MICAL 3 | 0.0138 | 0.4448 | 0.4448 |
Leishmania major | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0829 | 0.0829 |
Onchocerca volvulus | 0.0058 | 0.1471 | 1 | |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 50 uM | PUBCHEM_BIOASSAY: Factor XIIa 1536 HTS Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID800] | ChEMBL. | No reference |
Potency (functional) | 0.0029 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.